Scrutinzer Report
Bliss GVS Pharma Ltd has submitted to BSE a copy of the Scrutinzer Report of evoting & poll for declaring the result of 30th Annual General Meeting of the Company held on September 16, 2015.24-09-2015
24-09-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shruti N Kamath has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201122-09-2015
Outcome of AGM
Bliss GVS Pharma Ltd has informed BSE that the 30th Annual General Meeting (AGM) of the Company was held on September 16, 2015.16-09-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Bliss GVS Pharma Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201124-08-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Bliss GVS Pharma Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201124-08-2015
Outcome of Board Meeting
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2015, inter alia, has considered and approved the following;1. Mr. Vipul B. Thakkar appointed as the Chief Financial Officer (CFO) of the Company.2. Adopted (a) Secretarial Standard-1 (SS-1) on "Meetings of the Board of Directors and (b) Secretarial Standard-2 (SS-2) on General Meetings.14-08-2015
Financial Results & Limited Review Report for June 30, 2015 (Standalone)
Bliss GVS Pharma Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2015.14-08-2015
Closure of Trading Window
Bliss GVS Pharma Ltd has informed BSE that the Board meeting of the Company for the quarter ended June 30, 2015 is scheduled to be held on August 14, 2015, inter alia, to consider the un-audited financial results of the Company for the Quarter ended June 30, 2015.Further, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 read with the provisions of the code of fair Disclosure of the...05-08-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Gautam Ashra has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201104-08-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Bliss GVS Pharma Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201104-08-2015